TNF and obesity due to melanocortin 4 receptor deficiency: Similar results were confirmed by observational studies including early-RA patients, in whom both obesity and overweight confer a lower chance to obtain remission or low disease activity, irrespective of treatment with DMARDs or anti-TNF therapy (86, 97, 98).